Skip to main content
Back to feed
HealthConfirmedMedium
5.5

Mounjaro Swedish sales top 2B kronor in September, record pace

Mounjaro (tirzepatide) has surpassed 2 billion kronor in Swedish sales in September alone, per the E-health Agency, a record for the drug in that market. The figure signals accelerating demand for GLP-1/GIP therapies in Sweden, though it is a single-market data point. This matters as it underscores the commercial momentum of obesity/diabetes drugs, which could influence pharma sector expectations.

Dagens Industriabout 7 hours agoSECredibility 26%View source

Score Breakdown

Mosaic Score5.5
Confidence0.5
Significance0.5
Source credibility0.3

Intelligence Tags

#mounjaro#tirzepatide#glp-1#pharmaceuticals#sales#sweden

Locations

Sweden

Entities

country
Source

Related signals

8 found